Identification and immunolocalization of a new class of proteoglycan (Keratan sulfate) to the neuritic plaques of Alzheimer's disease

Experimental Neurology

Volumn 138, Issue 2, 1996, Pages 305-317

  Snow, Alan D ^a   Nochlin, David ^a   Sekiguchi, Raymond ^a   Carlson, Steven S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KERATAN SULFATE; PROTEOGLYCAN; SYNAPTOPHYSIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SENILE PLAQUE; SYNAPSE VESICLE;

EID: 0029881267     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0069     Document Type: Article

References (81)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501.
2. AILLES, L., R. KISILEVSKY, AND I. D. YOUNG. 1993. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. Lab. Invest. 69: 443-447.
3. BAJJALIEH, S. M., K. PETERSON, R. SHINGHAL, AND R. H. SCHELLER. 1992. SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science 257: 1271-1273.
4. BINDRA, P. S., R. KNOWLES, AND K. BUCKLEY. 1993. Conservation of amino acid sequence of SV2, a transmembrane transporter in synaptic vesicles and endocrine cells. Gene 137: 299-302.
5. BUCKLEY, K., AND R. KELLY. 1985. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J. Cell Biol. 100: 1284-1294.
6. BUEE, L., W. DING, J. P. ANDERSON, S. NARINDRASORASAK, R. KISILEVSKY, N. J. BOYLE, N. K. ROBAKIS, A. DELACOURTE, B. GREENBERG, AND H. M. FILLIT. 1993. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res. 627: 199-204.
7. BUEE, L., W. DING, A. DELACOURTE, AND H. FILLIT. 1993. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res. 601: 154-163.
8. CANNING, D. R., R. J. MCKEON, D. A. DEWHITT, G. PERRY, J. R. WUJEK, R. C. A. FREDERICKSON AND J. SILVER. 1993. β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp. Neurol. 124: 289-298.
9. CARLSON, S. S., AND R. B. KELLY. 1983. A highly antigenic proteoglycan-like component of cholinergic synaptic vesicles. J. Biol. Chem. 258: 11082-11091.
10. CORIA, F., E. CASTANO, F. PRELLI, M. LILLO-LARRONDO, S. VAN DUINEN, M. L. SHELANSKI, AND B. FRANGIONE. 1988. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidoses. Lab. Invest. 58: 454-458.
11. CORK, L. C., C. MASTERS, K. BEYREUTHER, AND D. L. PRICE. 1990. Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits. Am. J. Pathol. 137: 1383-1392.
12. DEKOSKY, S. T., AND S. W. SCHEFF. 1990. Synaptic loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27: 457-464.
13. DEWITT, D. A., J. SILVER, D. R. CANNING, AND G. PERRY. 1993. Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp. Neurol. 121: 149-152.
14. EARLE, K. E. 1964. Examination of the brain (necroscopy technique). American Registry of Pathology. Armed Forces Institute of Pathology, Washington, DC.
15. EIKELENBOOM, P., C. E. HACK, J. M. ROZEMULLER, AND F. C. STAM. 1989. Complement activation in amyloid plaques in Alzheimer's dementia. Virch. Arch. B Cell Pathol. 56: 259-262.
16. FEANY, M. B., S. LEE, R. H. EDWARDS, AND K. M. BUCKLEY. 1992. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell 70: 861-867.
17. FRASER, P. E., J. T. NGUYEN, D. T. CHIN, AND D. A. KIRSCHNER 1992. Effect of sulfate ions on Alzheimer β/A4 assemblies: implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59: 1531-1540.
18. GEDDES, J. W., K. J. ANDERSON, AND C. W. COTMAN. 1986. Senile plaques as aberrant sprout stimulating structures. Exp. Neurol. 94: 767-776.
19. GIACCONE, G., F. TAGLIAVINI, G. LINOLI, C. BOURAS, L. FRIGERIO, B. FRANGIONE, AND O. BUGIANI. 1989. Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci. Lett. 97: 232-238.
20. GINGRICH, J. A., P. H. ANDERSEN, M. TIBERI, S. MESTIKAWY, P. N. JORGENSEN, R. T. FREMEAU, AND M. G. CARON. 1992. Identification, characterization, and molecular cloning of a novel transporter-like protein localized to the central nervous system. FEBS 312: 115-122.
21. GLENNER, G. G., AND C. W. WONG. 1984. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890.
22. GONATAS, N. K., W. W. ANDERSON, AND I. EVANGELISTA. 1967. The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 26: 25-39.
23. GRUMET, M., A. FLACCUS, AND R. U. MARGOLIS. 1993. Functional characterization of chondroitin sulfate proteoglycans of brain: Interactions with neurons and neural cell adhesion molecules. J. Cell Biol. 120: 815-824.
24. GRUNDKE-IQBAL, I., K. IQBAL, Y. TUNG, M. QUINLAN, H. M. WISNIEWSKI, AND L. I. BINDER. 1986. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83: 4913-4917.
25. HEFTI, F., AND W. J. WEINER. 1986. Nerve growth factor and Alzheimer's disease. Ann. Neurol. 20: 275-281.
26. HEFTI, F., J. HARTIKKA, AND B. KNUSEL. 1989. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol. Aging 10: 515-533.
27. HOCKFIELD, S., S. S. CARLSON, P. LEVITT, C. EVANS, AND L. SILBERSTEIN. 1993. Molecular Probes of the Nervous System. Cold Spring Harbor Press, Cold Spring Harbor, New York.
28. HSU, S. M., L. RAINE, AND H. FANGER. 1981. Use of avidin biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577-580.
29. HUSBY, G., S. ARAKI, E. P. BENDITT, M. D. BENSON, A. S. COHEN, B. FRANGIONE, G. G. GLENNER, J. B. NATVIG, AND P. WESTERMARK. 1993. Nomenclature of amyloid and amyloidosis. Bull. WHO 71: 105-108.
30. IWATA, M., AND S. S. CARLSON. 1991. A large chondroitin sulfate basement membrane-associated proteoglycan exists as a disulfide-stabilized complex of several proteins. J. Biol. Chem. 266: 323-333.
31. FLINT, M. H., A. S. CRAIG, H. C. REILLY, G. C. GILLARD, AND D. A. PARRY. 1984. Collagen fibril diameters and glycosaminoglycan content of skins-indices of tissue maturity and function. Connect. Tissue Res. 13: 69-81.
32. JOACHIM, C. L., J. H. MORRIS, D. J. SELKOE, AND K. S. KOSIK. 1987. Tau epitopes are incorporated into a range of lesions in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 46: 611-622.
33. JOACHIM, C. L., J. H. MORRIS, AND D. J. SELKOE. 1989. Diffuse senile plaques occur commonly in the cerebellum of Alzheimer's disease. Am. J. Pathol. 135: 309-319.
34. KATO, M., H. WANG, M. BERNFIELD, J. T. GALLAGHER, AND J. E. TURNBULL. 1994. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. J. Biol. Chem. 269: 18881-18890.
35. KATO, T., H. SASAKI, T. KATAGIRI, K. KOIWAI, H. YOUKI, S. TOTSUKA, AND T. ISHII. 1991. The binding of bFGF to Alzheimer's disease neurofibrillary tangles and senile plaques. Neuroscience 122: 33-36.
36. KITAMOTO, T., K. OGOMORI, J. TATEISHI, AND S. B. PRUSINER 1987. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab. Invest. 57: 230.
37. KOSIK, K. S., C. L. JOACHIM, AND D. J. SELKOE. 1986. Microtubule-associated protein tau is a major antigenic component of paired helical filaments in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 83: 4044-4048.
38. LAEMMLI, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
39. LASSMANN, H., R. WEILER, P. FISCHER, C. BANCHER, K. JELLINGER, E. FLOOR, W. DANIELCZYK, F. SEITELBERGER, AND H. WINKLER. 1992. Synaptic pathology in Alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles. Neuroscience 46: 1-8.
40. LEE, V. M. Y., B. J. BALIN, L. OTVOS JR., AND J. Q. TROJANOWSKI. 1991. A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251: 675-678.
41. MASLIAH, E., R. D. TERRY, M. MALLORY, M. ALFORD, AND L. A. HANSEN. 1990. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am. J. Pathol. 137: 1293-1297.
42. MASLIAH, E., L. HANSEN, T. ALBRIGHT, M. MALLORY, AND R. D. TERRY. 1991. Immunoelectron microscopic study of synaptic pathology in Alzheimer disease. Acta Neuropathol. 81: 428-433.
43. MASLIAH, E., R. D. TERRY, M. ALFORD, R. DETERESA, AND L. A. HANSEN. 1991. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am. J. Pathol. 138: 235-246.
44. MASLIAH, E., M. MALLORY, N. GE, AND T. SAITOH. 1992. Protein kinases and growth associated proteins in plaque formation in Alzheimer's disease. Rev. Neurosci. 3: 99-107.
45. MASLIAH, E., W. G. HONER, M. MALLORY, M. VOIGT, P. KUSHNER, L. HANSEN, AND R. TERRY. 1994. Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus. Acta Neuropathol. 87: 135-142.
46. MASTERS, C. L., G. SIMMS, N. A. WEINMAN, G. MULTHAUP, B. L. DONALD, AND K. BEYREUTHER 1985. Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. USA 82: 4245-4249.
47. MCCUBBIN, W. D., C. M. KAY, S. NARINDRASORASAK, AND R. KISILEVSKY. 1988. Circular dichroism and fluorescence studies on two murine serum amyloid A proteins. Biochem. J. 256: 775-783.
48. MCGEER, P. L., H. AKIYAMA, S. HAGAKI, AND E. G. MCGEER. 1989. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16: 516-527.
49. MCKEE, A. C., K. S. KOSIK, AND N. W. KOWALL. 1991. Neuritic pathology and dementia in Alzheimer's disease. Ann. Neurol. 30: 156-165.
50. MORI, H., J. KONDO, AND Y. IHARA. 1987. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235: 1641-1644.
51. MUKAETOVA-LADINSKA, E. B., C. R. HARRINGTON, M. ROTH, AND C. M. WISCHIK. 1993. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Am. J. Pathol. 143: 565-578.
52. NARINDRASORASAK, S., D. E. LOWRY, P. A. GONZALEZ-DEWHITT, R. A. POORMAN, B. D. GREENBERG, AND R. KISILEVSKY. 1991. High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266: 12878-12883.
53. OBRINK, B. 1975. The influence of glycosaminoglycans on the formation of fibers from monomeric tropocollagen in vitro. Eur. J. Biochem. 31: 129-137.
54. OOHIRA, A., F. MATSUI, AND S. R. KATOH. 1991. Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells. J. Neurosci. 11: 822-827.
55. PAPASOZOMENOS, S. C. 1989. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. Lab. Invest. 60: 123-137.
56. PERLMUTTER, L. S., H. C. CHUI, D. SAPERIA, AND J. ATHANIKAR 1990. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res. 508: 13-19.
57. PERLMUTTER, L. S., AND H. C. CHUI. 1990. Microangiopathy, the vascular basement membrane and Alzheimer's disease: A review. Brain Res. Bull. 24: 677-686.
58. PERRY, G., R. FREIDMAN, G. SHAW, AND V. CHAU. 1987. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites in Alzheimer's disease brain. Proc. Natl. Acad. Sci. USA 84: 3033-3036.
59. PERRY, G., S. L. SIEDLAK, P. REICHEY, M. KAWAI, P. CRAS, R. N. KALARIA, P. G. GALLOWAY, J. M. SCARDINA, B. CORDELL, B. D. GREENBERG, S. R. LEDBETTER, AND P. GAMBETTI. 1991. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J. Neurosci. 11: 3679-3683.
60. PUCHTLER, H., F. SWEAT, AND M. LEVINE. 1962. On the binding of congo red by amyloid. J. Histochem. Cytochem. 10: 355-364.
61. ROGERS, J. 1994. Inflammation and Alzheimer's disease. CNS Drugs 4: 241-244.
62. SCOTT, J. E. 1988. Proteoglycan-fibrillar collagen interactions. Biochem. J. 252: 313-323.
63. SCRANTON, T. W., M. IWATA, AND S. S. CARLSON. 1993. The SV2 protein of synaptic vesicles is a keratan sulfate proteoglycan. J. Neurochem. 61: 24-44.
64. SNOW, A. D., H. MAR, D. NOCHLIN, K. KIMATA, M. KATO, S. SUZUKI, J. HASSELL, AND T. N. WIGHT. 1988. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy of Alzheimer's disease. Am. J. Pathol. 133: 456-463.
65. SNOW, A. D., M. G. KINSELLA, P. B. PRATHER, D. NOCHLIN, M. B. PODLISNY, D. J. SELKOE, R. KISILEVSKY, J. R. HASSELL, AND T. N. WIGHT. 1989. A characteristic binding affinity between heparan sulfate proteoglycans and the A4 amyloid protein of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 48: 352. [Abstract]
66. SNOW, A. D., AND T. N. WIGHT. 1989. Proteoglycans in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 10: 481-497.
67. SNOW, A. D., H. MAR, D. NOCHLIN, R. T. SEKIGUCHI, K. KIMATA, Y. KOIKE, AND T. N. WIGHT. 1990. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137: 1253-1270.
68. SNOW, A. D., H. MAR, D. NOCHLIN, H. KRESSE, AND T. N. WIGHT. 1992. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J. Histochem. Cytochem. 40: 105-113.
69. SNOW, A. D., R. SEKIGUCHI, D. NOCHLIN, P. FRASER, K. KIMATA, A. MITZUTANI, M. ARAI, W. A. SCHREIER, AND D. G. MORGAN. 1994. An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ amyloid in rat brain. Neuron 12: 219-234.
70. SNOW, A. D., R. SEKIGUCHI, D. NOCHLIN, R. N. KALARIA, AND K. KIMATA. 1994. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not in cerebellum of Alzheimer's disease brain. Am. J. Pathol. 144: 337-347.
71. SNOW, A. D., M. G. KINSELLA, E. PARKS, R. T. SEKIGUCHI, J. D. MILLER, K. KIMATA, AND T. N. WIGHT. 1995. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin and versican) to the beta-amyloid protein of Alzheimer's disease. Arch. Biochem. Biophys. 320: 84-95.
72. SNOW, D. M., V. LEMMON, D. A. CARRINO, A. I. CAPLAN, AND J. SILVER. 1990. Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp. Neurol. 109: 111-130.
73. SNOW, D. M., AND P. C. LETOURNEAU. 1992. Neurite outgrowth on a step gradient of chondroitin sulfate proteoglycan (CS-PG). J. Neurobiol. 23: 322-336.
74. STERNBERGER, L. W. 1986. Immunocytochemistry, 3rd ed. Wiley, New York.
75. SU, J. H., B. J. CUMMINGS, AND C. W. COTMAN. 1992. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51: 801-813.
76. TOOYAMA, I., H. AKIYAMA, P. L. MCGEER, Y. HARA, D. YASUHARA, AND H. KIMURA. 1991. Acidic fibroblast growth factor-like immunoreactivity in brain of Alzheimer's disease patients. Neurosci. Lett. 121: 155-158.
77. VAN GOOL, D., G. DAVID, M. LAMMENS, F. BARO, AND R. DOM. 1993. Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia. Dementia 4: 308-314.
78. VAN KUPPEVELT, T. H. M. S. M., H. M. J. JANSSEN, H. M. V. BEUNINGEN, K. CHEUNG, M. M. A. SCHIJEN, C. M. A. KUYPER, AND J. H. VEERKAMP. 1987. Isolation and characterization of a collagen fibril-associated dermatan sulfate proteoglycan from bovine lung. Biochim. Biophys. Acta 926: 296-309.
79. VOGEL, K. G., M. PAULSSON, AND D. HEINEGARD. 1984. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 223: 587-597.
80. WEILER, R., H. LASSMANN, P. FISCHER, K. JELLINGER, AND H. WINKLER 1990. A high ratio of chromogranin A to synaptin/ synaptophysin is a common feature of brains in Alzheimer and Pick disease. FEBS 263: 337-339.
81. YAMAGUCHI, H., H. NAKAZATO, S. HIRAI, M. SHOJI, AND Y. HARIGAYA. 1989. Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain. Am. J. Pathol. 135: 593-597.